Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
US5114916A · kind A · utility
18Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 14, 1990 |
| Grant date | May 19, 1992 |
| Priority date | — |
| Expiry date | Feb 14, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Human blood coagulation factor XIII allows the prevention of intraventricular hemorrhage when administered to premature infants, preferably by intravenous injections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.